21 CFR 520.563

§ 520.563 Diatrizoate.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.563, § 520.563 Diatrizoate, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87122
Permanent ID: ys:prov:87122@1
SHA-256: 99856de7189438c35f0f295e5a2e66d8b5b0717bc140a2c10f2cbab4200a2175

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Diatrizoate meglumine oral solution is a water soluble radiopaque medium containing 66 percent diatrizoate meglumine and 10 percent diatrizoate sodium. (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter. (c) Conditions of use in dogs and cats—(1) Amount. Administer orally 0.5 to 1.0 milliliter per pound of body weight by gavage or stomach tube. Administered rectally 0.5 to 1.0 milliliter per pound of body weight diluted with 1 part of the drug to 5 parts of water. (2) Indications for use. For radiography of the gastrointestinal tract. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.